Skip to main content

. 2021 Jul 16;147(9):2545–2546. doi: 10.1007/s00432-021-03736-x

Correction to: Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer

Wanting Shao ^1,², Christina Kuhn ³, Doris Mayr ⁴, Nina Ditsch ³, Magdalena Kailuwait ¹, Verena Wolf ¹, Nadia Harbeck ¹, Sven Mahner ¹, Udo Jeschke ^1,^3,^✉, Vincent Cavaillès ⁵, Sophie Sixou ^1,^6,⁷

PMCID: PMC8587370 PMID: 34269882

Correction to: Journal of Cancer Research and Clinical Oncology 10.1007/s00432-021-03670-y

In the original article, the Fig. 2 is published incorrectly. The correct Fig. 2 is given below.

Fig. 2 — Kaplan–Meier analyses of patient overall survival (OS) in the whole cohort according to nuclear, cytoplasmic, and total LXR expression. OS Kaplan–Meier curves are presented according to total (A), nuclear (B), and cytoplasmic (C) LXR expression. The optimal IRS cut-off values for nuclear, cytoplasmic, and total LXR expression were determined as 2.5, 5, and 8.5, respectively. The number of cases for each group is indicated in each penal

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

ACTIONS

RESOURCES